Kevin R Thornal insider trades: Zimmer Biomet Holdings (ZBH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ZBH | ↓ Sell | 5,691 | $92.95 | $529K | Direct | Sep 15, 2026 (4d) |
| Nov 15, 2022 | HOLX | ↓ Sell | 19,118 | $75.32 | $1.4M | Direct | Nov 17, 2022 (2d) |
| Dec 10, 2020 | HOLX | ↓ Sell | 16,869 | $73.99 | $1.2M | Direct | Dec 14, 2020 (4d) |
| May 15, 2020 | HOLX | ↓ Sell | 13,888 | $51.51 | $715K | Direct | May 19, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ZBH insiders
Open-market trades in the last 12 months
About Kevin R Thornal's insider trades
Kevin R Thornal is Grp Pres-Global Business at Zimmer Biomet Holdings (ZBH). Since May 15, 2020, Kevin has reported no open-market purchases and 4 sales worth $3.9M on SEC Form 4. In the last 12 months: 1 sale ($529K).
Their filings also include shares withheld for taxes (15 filings), grants and awards (11 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZBH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.